Literature DB >> 11378579

Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells.

R Krishna Narla1, C Navara, M Sarquis, F M Uckun.   

Abstract

The TEL-AML1 fusion which results from a cryptic t(12;21) translocation is the most frequently occurring genetic abnormality in childhood acute lymphoblastic leukemia (ALL) and has been associated with an excellent treatment outcome. In the present study, we examined the FAS/BCL-2 expression profiles and chemosensitivity of primary leukemic cells from children with newly diagnosed t(12;21)TEL-AML1 fusion transcript-positive versus t(12;21)TEL-AML1 fusion transcript-negative standard risk ALL. TEL-AML1(+) ALL cells expressed higher levels of the pro-apoptotic protein Fas and lower levels of the anti-apoptotic protein Bcl2 than TEL-AML1(-) ALL cells, as determined by confocal laser scanning microscopy. TEL-AML1(+) ALL cells were more sensitive to the apoptosis-inducing effects of serum deprivation, dexamethasone and vincristine than TEL-AML1(-) ALL cells. This study provides novel mechanistic insights regarding the chemosensitivity of TEL-AML1(+) ALL cells and provides a cogent explanation for the excellent leukemia-free survival outcome of children with TEL-AML1(+) ALL treated on contemporary chemotherapy programs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378579     DOI: 10.3109/10428190109060352

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy.

Authors:  D Bhojwani; D Pei; J T Sandlund; S Jeha; R C Ribeiro; J E Rubnitz; S C Raimondi; S Shurtleff; M Onciu; C Cheng; E Coustan-Smith; W P Bowman; S C Howard; M L Metzger; H Inaba; W Leung; W E Evans; D Campana; M V Relling; C-H Pui
Journal:  Leukemia       Date:  2011-08-26       Impact factor: 11.528

2.  Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.

Authors:  Mignon L Loh; Meredith A Goldwasser; Lewis B Silverman; Wing-Man Poon; Shashaank Vattikuti; Angelo Cardoso; Donna S Neuberg; Kevin M Shannon; Stephen E Sallan; D Gary Gilliland
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

3.  ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.

Authors:  Yu Wang; Hui-Min Zeng; Le-Ping Zhang
Journal:  Ital J Pediatr       Date:  2018-08-16       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.